These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30452418)

  • 1. Aberrant Neuronal Cell Cycle Re-Entry: The Pathological Confluence of Alzheimer's Disease and Brain Insulin Resistance, and Its Relation to Cancer.
    Koseoglu MM; Norambuena A; Sharlow ER; Lazo JS; Bloom GS
    J Alzheimers Dis; 2019; 67(1):1-11. PubMed ID: 30452418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer's disease patients.
    Hradek AC; Lee HP; Siedlak SL; Torres SL; Jung W; Han AH; Lee HG
    J Alzheimers Dis; 2015; 43(1):57-65. PubMed ID: 25061053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in AppNLF Knock-In Mice.
    Barrett T; Stangis KA; Saito T; Saido T; Park KHJ
    J Alzheimers Dis; 2021; 82(4):1683-1702. PubMed ID: 34219712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin-mimetic novel nonapeptide rescues aberrant neuronal metabolic-associated memory deficits in Alzheimer's disease.
    Ali T; Rehman SU; Khan A; Badshah H; Abid NB; Kim MW; Jo MH; Chung SS; Lee HG; Rutten BPF; Kim MO
    Mol Neurodegener; 2021 Apr; 16(1):23. PubMed ID: 33849621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle re-entry in Alzheimer's disease: a major neuropathological characteristic?
    Lopes JP; Oliveira CR; Agostinho P
    Curr Alzheimer Res; 2009 Jun; 6(3):205-12. PubMed ID: 19519302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological implications of cell cycle re-entry in Alzheimer disease.
    Bonda DJ; Lee HP; Kudo W; Zhu X; Smith MA; Lee HG
    Expert Rev Mol Med; 2010 Jun; 12():e19. PubMed ID: 20584423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reevaluation of tetraploidy in the Alzheimer's disease brain.
    Westra JW; Barral S; Chun J
    Neurodegener Dis; 2009; 6(5-6):221-9. PubMed ID: 19738367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
    Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
    Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.
    Atwood CS; Bowen RL
    J Alzheimers Dis; 2015; 47(1):33-47. PubMed ID: 26402752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease.
    Seward ME; Swanson E; Norambuena A; Reimann A; Cochran JN; Li R; Roberson ED; Bloom GS
    J Cell Sci; 2013 Mar; 126(Pt 5):1278-86. PubMed ID: 23345405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
    Lee HG; Casadesus G; Zhu X; Castellani RJ; McShea A; Perry G; Petersen RB; Bajic V; Smith MA
    Neurochem Int; 2009 Feb; 54(2):84-8. PubMed ID: 19114068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Polo-like kinase 1 reduces beta-amyloid-induced neuronal cell death in Alzheimer's disease.
    Song B; Davis K; Liu XS; Lee HG; Smith M; Liu X
    Aging (Albany NY); 2011 Sep; 3(9):846-51. PubMed ID: 21931181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer's Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling.
    Yuen SC; Lee SM; Leung SW
    J Alzheimers Dis; 2022; 85(3):1373-1398. PubMed ID: 34924393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking IGF Signaling in Adult Neurons Alleviates Alzheimer's Disease Pathology through Amyloid-β Clearance.
    Gontier G; George C; Chaker Z; Holzenberger M; Aïd S
    J Neurosci; 2015 Aug; 35(33):11500-13. PubMed ID: 26290229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
    Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM
    J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease.
    Rao CV; Asch AS; Carr DJJ; Yamada HY
    Aging Cell; 2020 Mar; 19(3):e13109. PubMed ID: 31981470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell cycle regulatory failure in neurones: causes and consequences.
    Nagy Z
    Neurobiol Aging; 2000; 21(6):761-9. PubMed ID: 11124420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation end products are mitogenic signals and trigger cell cycle reentry of neurons in Alzheimer's disease brain.
    Kuhla A; Ludwig SC; Kuhla B; Münch G; Vollmar B
    Neurobiol Aging; 2015 Feb; 36(2):753-61. PubMed ID: 25448604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cell cycle molecules behind neurodegeneration in Alzheimer's disease: perspectives for drug development.
    Copani A; Guccione S; Giurato L; Caraci F; Calafiore M; Sortino MA; Nicoletti F
    Curr Med Chem; 2008; 15(24):2420-32. PubMed ID: 18855671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.